iraes, treatments for checkpoint inhibitor inflammatory arthritis and pmr
Published 4 years ago • 132 plays • Length 5:58Download video MP4
Download video MP3
Similar videos
-
1:02:47
“rheumatologic consequences of immune checkpoint inhibitors”, annual kessler lecture, dr. ami shah
-
5:24
panel presentation: understanding iraes from immune checkpoint inhibitors
-
0:19
understanding inflammatory arthritis in cancer patients caused by checkpoint inhibitors (:18)
-
1:30
inflammatory arthritis persists after immunotherapy cessation: dr. david liew
-
3:02
latent class analysis identifies 2 clinical phenotypes of immune checkpoint inhibitor-induced
-
1:04:36
rheumatology, immunology, and immuno-oncology intersect: navigating the complexities of iraes
-
58:19
medicine grand rounds: rheumatology 2/27/18
-
9:38
b7-h4_ a new frontier in immune checkpoint inhibition
-
26:46
rheumnow day 3 recap: acr convergence 2024 highlights
-
45:59
immune checkpoint inhibitors in solid tumours
-
9:46
which pmr patients should rheumatologists see?
-
5:31
asp015k in patients with rheumatoid arthritis and an inadequate response to conventional dmards
-
6:26
treatment options for rheumatoid arthritis | johns hopkins rheumatology
-
7:25
how to manage toxicities from immune checkpoint inhibitors?
-
27:19
inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab
-
56:25
dissecting toxicities of immune checkpoint inhibitors with dr. douglas johnson, m.d., msci
-
1:31
risk-adjusted safety analysis of pacritinib for patients with mf
-
6:20
jak inhibitor treatment shows benefit for patients with interferonopathies
-
2:39
severity of immune checkpoint inhibitors' side effects